Editorial
Oral ondansetron: a useful addition to the supportive care armamentarium?
- PMID: 8141106
Item in Clipboard
Editorial
Oral ondansetron: a useful addition to the supportive care armamentarium?
Am J Clin Oncol.
1994 Apr.
No abstract available
Comment on
-
Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group.Am J Clin Oncol. 1994 Apr;17(2):137-46. doi: 10.1097/00000421-199404000-00010. Am J Clin Oncol. 1994. PMID: 8141105 Clinical Trial.
Similar articles
-
Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.Cancer J Sci Am. 1998 Jan-Feb;4(1):52-8. Cancer J Sci Am. 1998. PMID: 9467047 Clinical Trial.
-
[Optimal control by ondansetron of acute and prolonged emesis induced by chemotherapy without cisplatin].Bull Cancer. 1996 Jan;83(1):71-76. Bull Cancer. 1996. PMID: 8672859 Review. French.
-
[Evaluation of the anti-emetic effectiveness of two drug formulations of Ondansetron in combined chemotherapy for children with malignant tumors].Vopr Onkol. 1999;45(4):424-8. Vopr Onkol. 1999. PMID: 10532104 Clinical Trial. Russian.
-
Single 8 mg dose of oral ondansetron failed to prevent FAC chemotherapy-induced acute nausea and vomiting.J Chemother. 1996 Aug;8(4):315-8. doi: 10.1179/joc.1996.8.4.315. J Chemother. 1996. PMID: 8873840 Clinical Trial.
-
Update on anti-emetics for chemotherapy-induced emesis.Intern Med J. 2005 Aug;35(8):478-81. doi: 10.1111/j.1445-5004.2005.00879.x. Intern Med J. 2005. PMID: 16176471 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical